EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer

Satvik Tripathi iD, Azadeh Tabari iD, Arian Mansur iD, Harika Dabbara, Christopher P Bridge, Dania Daye

Diagnostics · 12.01.2024 · 14 (2) · 174

DOI: 10.3390/diagnostics14020174 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 12.01.2024. Verfasst von Satvik Tripathi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, USA. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer is a highly aggressive and difficult-to-detect cancer with a poor prognosis. Late diagnosis is common due to a lack of early symptoms, specific markers, and the challenging location of the pancreas. Imaging technologies have improved diagnosis, but there is still room for improvement in standardizing guidelines. Biopsies and histopathological analysis are challenging due to tumor heterogeneity. Artificial Intelligence (AI) revolutionizes healthcare by improving diagnosis, treatment, and patient care. AI algorithms can analyze medical images with precision, aiding in early disease detection. AI also plays a role in personalized medicine by analyzing patient data to tailor treatment plans. It streamlines administrative tasks, such as medical coding and documentation, and provides patient assistance through AI chatbots. However, challenges include data privacy, security, and ethical considerations. This review article focuses on the potential of AI in transforming pancreatic cancer care, offering improved diagnostics, personalized treatments, and operational efficiency, leading to better patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligence (AI)artificial neural network (ANN)future perspectivesmachine learning (ML)pancreatic adenocarcinoma (PAC)review

Autor:innen und Institutionen

  • Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA 02129, USA.
  • Harvard Medical School, Boston, MA 02115, USA.
  • Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.

ORCID-Profile: Satvik Tripathi, Azadeh Tabari, Arian Mansur

Zitieren

APA

Tripathi, S., Tabari, A., Mansur, A., Dabbara, H., Bridge, C. P., & Daye, D. (2024). From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer. Diagnostics, 14(2), 174. https://doi.org/10.3390/diagnostics14020174

Vancouver

Tripathi S, Tabari A, Mansur A, Dabbara H, Bridge CP, Daye D. From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer. Diagnostics. 2024;14(2):174. doi:10.3390/diagnostics14020174

BibTeX
@article{Tripathi2024,
  author = {Tripathi, Satvik and Tabari, Azadeh and Mansur, Arian and Dabbara, Harika and Bridge, Christopher P and Daye, Dania},
  title = {From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer},
  journal = {Diagnostics},
  year = {2024},
  volume = {14},
  number = {2},
  pages = {174},
  doi = {10.3390/diagnostics14020174}
}
Kostenlos starten →